Drugs / Gentamicine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07300553 | Jan → Nov 2026 expected | Crohn disease, ulcerative colitis | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gentamicine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07300553 ↗ |
| Route | Oral | “Dose 80mg x4 daily orally” NCT07300553 ↗ |